Sandy Spring Bank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $46.1K | Sell |
636
-850
| -57% | -$60.8K | ﹤0.01% | 589 |
|
|
2024
Q4 | $110K | Sell |
1,486
-182
| -11% | -$12.7K | ﹤0.01% | 444 |
|
|
2024
Q3 | $110K | Sell |
1,668
-73
| -4% | -$5.3K | ﹤0.01% | 447 |
|
|
2024
Q2 | $161K | Sell |
1,741
-1,169
| -40% | -$104K | 0.01% | 390 |
|
|
2024
Q1 | $278K | Hold |
2,910
| – | – | 0.01% | 337 |
|
|
2023
Q4 | $222K | Hold |
2,910
| – | – | 0.01% | 348 |
|
|
2023
Q3 | $202K | Hold |
2,910
| – | – | 0.01% | 343 |
|
|
2023
Q2 | $275K | Sell |
2,910
-1,054
| -27% | -$91.6K | 0.01% | 320 |
|
|
2023
Q1 | $328K | Buy |
3,964
+1,046
| +36% | +$82.2K | 0.02% | 287 |
|
|
2022
Q4 | $218K | Buy |
2,918
+80
| +3% | +$6.17K | 0.01% | 326 |
|
|
2022
Q3 | $234K | Buy |
2,838
+1,203
| +74% | +$116K | 0.01% | 310 |
|
|
2022
Q2 | $155K | Sell |
1,635
-8
| -0.5% | -$828 | 0.01% | 351 |
|
|
2022
Q1 | $193K | Buy |
1,643
+50
| +3% | +$5.61K | 0.01% | 336 |
|
|
2021
Q4 | $206K | Hold |
1,593
| – | – | 0.01% | 332 |
|
|
2021
Q3 | $180K | Hold |
1,593
| – | – | 0.01% | 342 |
|
|
2021
Q2 | $165K | Buy |
1,593
+672
| +73% | +$63.3K | 0.01% | 357 |
|
|
2021
Q1 | $77K | Sell |
921
-174
| -16% | -$14.7K | ﹤0.01% | 450 |
|
|
2020
Q4 | $100K | Buy |
1,095
+234
| +27% | +$19.4K | 0.01% | 387 |
|
|
2020
Q3 | $69K | Sell |
861
-9
| -1% | -$702 | ﹤0.01% | 422 |
|
|
2020
Q2 | $60K | Hold |
870
| – | – | ﹤0.01% | 432 |
|
|
2020
Q1 | $54K | Hold |
870
| – | – | ﹤0.01% | 426 |
|
|
2019
Q4 | $67K | Buy |
870
+420
| +93% | +$32.8K | ﹤0.01% | 429 |
|
|
2019
Q3 | $33K | Buy |
450
+93
| +26% | +$6.53K | ﹤0.01% | 534 |
|
|
2019
Q2 | $22K | Buy |
357
+51
| +17% | +$3.08K | ﹤0.01% | 592 |
|
|
2019
Q1 | $19K | Buy |
306
+174
| +132% | +$9.93K | ﹤0.01% | 588 |
|
|
2018
Q4 | $7K | Hold |
132
| – | – | ﹤0.01% | 695 |
|
|
2018
Q3 | $8K | Hold |
132
| – | – | ﹤0.01% | 691 |
|
|
2018
Q2 | $6K | Hold |
132
| – | – | ﹤0.01% | 703 |
|
|
2018
Q1 | $6K | Sell |
132
-300
| -69% | -$13K | ﹤0.01% | 729 |
|
|
2017
Q4 | $16K | Sell |
432
-900
| -68% | -$33K | ﹤0.01% | 618 |
|
|
2017
Q3 | $49K | Sell |
1,332
-942
| -41% | -$35.9K | ﹤0.01% | 444 |
|
|
2017
Q2 | $89K | Hold |
2,274
| – | – | 0.01% | 370 |
|
|
2017
Q1 | $72K | Buy |
2,274
+1,200
| +112% | +$37.6K | 0.01% | 403 |
|
|
2016
Q4 | $33K | Buy |
1,074
+132
| +14% | +$4.28K | ﹤0.01% | 502 |
|
|
2016
Q3 | $38K | Hold |
942
| – | – | ﹤0.01% | 477 |
|
|
2016
Q2 | $31K | Sell |
942
-600
| -39% | -$20.5K | ﹤0.01% | 515 |
|
|
2016
Q1 | $45K | Hold |
1,542
| – | – | 0.01% | 452 |
|
|
2015
Q4 | $41K | Buy |
+1,542
| New | +$40K | ﹤0.01% | 451 |
|
|
2014
Q1 | – | Sell |
-2,256
| Closed | -$25K | – | 744 |
|
|
2013
Q4 | $25K | Sell |
2,256
-180
| -7% | -$2.03K | ﹤0.01% | 449 |
|
|
2013
Q3 | $28K | Sell |
2,436
-2,400
| -50% | -$28.1K | ﹤0.01% | 415 |
|
|
2013
Q2 | $54K | Buy |
+4,836
| New | +$57.2K | 0.01% | 341 |
|
Other funds holding EW
Sandy Spring Bank's EW Position: Q1 2025 in Review
Sandy Spring Bank reduced its Edwards Lifesciences (EW) stake by 57% in Q1 2025, selling an estimated $60.8K and leaving 636 shares worth $46.1K. The position accounts for ﹤0.01% of the portfolio, ranked #589.
Sandy Spring Bank first reported a position in EW in Q2 2013 and has held it in 41 quarters since. The position peaked at $328K in Q1 2023. 1,205 funds tracked by Wall St. Rank hold EW as of Q1 2025.
- Sandy Spring Bank held 636 shares of Edwards Lifesciences worth $46.1K as of Q1 2025.
- Sandy Spring Bank sold 850 Edwards Lifesciences shares in Q1 2025, an estimated $60.8K.
- Edwards Lifesciences made up ﹤0.01% of Sandy Spring Bank's portfolio in Q1 2025, its #589 holding.
- Sandy Spring Bank first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 41 quarters since.
- Sandy Spring Bank's Edwards Lifesciences position peaked at $328K in Q1 2023.
- 1,205 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.
Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.